Tarragon (Artemisia dracunculus)

Tarragon (Artemisia dracunculus) contains bioactive chalcones such as davidigenin and 2',4'-dihydroxy-4-methoxydihydrochalcone, which modulate glucose uptake and insulin signaling pathways. Russian tarragon extract has demonstrated antihyperglycemic and anti-inflammatory activity primarily through inhibition of NF-κB and enhancement of GLUT4 translocation in preclinical models.

Origin & History

Tarragon (Artemisia dracunculus) is a perennial herb from the Asteraceae family, native to Eurasia. It is primarily cultivated for its aromatic leaves and flowering tops, with essential oil extracted via steam distillation.

Historical & Cultural Context

Tarragon has been used traditionally as a spice and remedy, particularly in Russian and French cultures, for digestive, anti-inflammatory, and hypoglycemic purposes. Its use is documented across Eurasian herbal systems.

Health Benefits

• Potential anti-inflammatory effects noted in rodent studies.
• Possible hepatoprotective benefits suggested by animal research.
• May exhibit antihyperglycemic properties as shown in in vivo rodent tests.
• Acts as a cholagogue, enhancing bile flow according to traditional use.
• Demonstrates spasmolytic activity, relieving muscle spasms in herbal traditions.

How It Works

Tarragon's chalcone compounds, particularly davidigenin and DMC2 (2',4'-dihydroxy-4-methoxydihydrochalcone), stimulate glucose uptake in skeletal muscle cells by promoting GLUT4 transporter translocation and activating the PI3K/Akt insulin signaling cascade. Its anti-inflammatory effects are mediated through suppression of NF-κB nuclear translocation, reducing downstream production of pro-inflammatory cytokines including TNF-α and IL-6. The cholagogue activity is attributed to flavonoids and volatile compounds such as methyl chavicol (estragole), which stimulate bile secretion from the gallbladder and support fat digestion.

Scientific Research

There are no key human clinical trials, RCTs, or meta-analyses available for tarragon. Evidence is limited to in vivo rodent studies and lacks human data with specific outcomes. No PMIDs are provided.

Clinical Summary

The majority of evidence supporting tarragon's benefits derives from rodent and in vitro studies rather than controlled human trials. A standardized Russian tarragon extract (PMI-5011) was studied in small human pilot trials involving type 2 diabetic subjects, showing modest reductions in postprandial glucose and improvements in insulin sensitivity, though sample sizes were under 30 participants. Animal studies using doses equivalent to 500–1000 mg/kg body weight demonstrated significant hepatoprotective effects, including reductions in serum ALT and AST levels. Overall, the clinical evidence base remains preliminary, and large randomized controlled trials in humans are lacking.

Nutritional Profile

Tarragon (Artemisia dracunculus) per 100g fresh herb: Calories ~295 kcal (dried), ~49 kcal (fresh). Macronutrients (fresh): Carbohydrates ~7.4g, Protein ~3.7g, Fat ~1.1g, Dietary Fiber ~2.4g. Key Micronutrients (fresh, notable concentrations): Vitamin A ~210 µg RAE (primarily from beta-carotene ~2500 µg), Vitamin C ~21 mg, Vitamin B6 (pyridoxine) ~2.4 mg (notably high, ~185% DV), Folate ~27 µg, Vitamin B2 (riboflavin) ~0.26 mg, Niacin ~8.95 mg (dried). Minerals: Iron ~32.3 mg (dried) / ~1.8 mg (fresh), Calcium ~1139 mg (dried) / ~90 mg (fresh), Magnesium ~347 mg (dried) / ~62 mg (fresh), Potassium ~3020 mg (dried) / ~338 mg (fresh), Manganese ~7.97 mg (dried), Zinc ~3.9 mg (dried), Phosphorus ~313 mg (dried). Bioactive Compounds: Phenylpropanoids — estragole (methyl chavicol) comprising 60–75% of essential oil (primary volatile); trans-anethole ~10–15% of essential oil; methyleugenol ~trace to 5%. Flavonoids: patuletin, quercetin, rutin, and isorhamnetin glycosides (~0.5–1.2% dry weight). Coumarins: herniarin and scopoletin (trace, <0.1%). Polyacetylenes: capillarin present in root fractions. Chlorogenic acid and caffeic acid detectable at ~0.3–0.8 mg/g dry weight. Sesquiterpenes including germacrene D and caryophyllene (~5–10% of essential oil). Bioavailability Notes: Fat-soluble carotenoids (beta-carotene) require dietary fat co-ingestion for absorption (~5–65% variable). Iron is non-heme form with lower bioavailability (~5–12%), enhanced by co-consumed vitamin C. Estragole is absorbed via gastrointestinal tract and undergoes hepatic metabolism (1'-hydroxylation); chronic high-dose exposure raises hepatotoxicity concerns, though culinary quantities (~1–5g fresh herb) are considered safe by EFSA. Flavonoid bioavailability is moderate (~20–50%) and enhanced by gut microbiota hydrolysis of glycoside forms. Russian tarragon (var. inodorus) contains significantly lower estragole and flavonoid concentrations compared to French tarragon (var. sativa).

Preparation & Dosage

No clinically studied dosage ranges are available due to the absence of human trials. Rodent studies suggest low doses, but specifics are not standardized. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

ginger, turmeric, cinnamon, rosemary, sage

Safety & Interactions

Tarragon consumed as a culinary herb is generally recognized as safe (GRAS), but concentrated supplements containing methyl chavicol (estragole) have raised concerns due to its potential hepatocarcinogenic properties in rodents at high doses. Individuals taking antidiabetic medications such as metformin or insulin should use tarragon supplements cautiously, as additive hypoglycemic effects may increase the risk of low blood sugar. Tarragon may also interact with anticoagulant drugs like warfarin due to its coumarin content, potentially altering bleeding time. Pregnant and breastfeeding women should avoid supplemental doses, as estragole exposure at elevated levels poses uncharacterized developmental risks.